|
|
|
|
hairy cell leukemia
A rare type of leukemia in which abnormal B-lymphocytes (a type of white blood cell) are present in the bone marrow, spleen, and peripheral blood. When viewed under a microscope, these cells appear to be covered with tiny hair-like projections. (National Cancer Institute)
BioCryst Pharmaceuticals Successfully Completes Phase I Trial With ... Mar 15, 2005
CTCL; chronic lymphocytic leukemia (CLL) and related leukemias including prolymphocytic leukemia, adult T-cell leukemia, and hairy cell leukemia; and for ... PR Newswire (press release)
Atypical Presentation of Anti-Rg a Mar 1, 2005
We report the case of a 70-yr-old man who presented with a medical history of hairy cell leukemia and profound pancytopenia that required RBC and platelet (PLT ... Annals of Clinical & Laboratory Science,
Scripps site roulette propels murmurs at gala Feb 13, 2005
...courses, Lerner told the 750 attendees that scientists at Scripps developed the cure for one of the rarest forms of blood cancer, known as hairy-cell leukemia. ... Palm Beach Post,
SuperGen Reports 2004 Fourth Quarter and Year-End Financial ... Feb 24, 2005
Nipent in combination with other chemotherapeutic agents, to treat chemotherapy-naove B-cell Chronic Lymphocytic Leukemia (CLL) and Hairy Cell Leukemia patients ... PR Newswire (press release)
Archives: The following articles may no longer be available on the web. If you want to inquire on a particular article, please contact the source publication (listed in parentheses).
FDA approval for Cladribine to treat active Hairy Cell Leukemia Apr 27, 2004
Cladribine is indicated for the treatment of active Hairy Cell Leukemia, and is the generic equivalent of Ortho Biotech's Leustatin(R) Injection. ... New-Medical.net
Mitsubishi cuts jobs May 22, 2004
SuperGen said a pre-clinical study indicates that its anti-cancer drug Nipent, which is currently sold to treat patients with hairy cell leukemia, can also be ... San Mateo County Times
SuperGen Announces Study of Novel Regimen Using Nipent(R) for ... May 21, 2004
Nipent® is currently approved as a single-agent treatment for patients with hairy cell leukemia and is not approved as either a single agent or as part of a ... Yahoo News (press release) - May 21, 2004
... Nipent® is currently approved as a single-agent treatment for patients with hairy cell leukemia and is not approved as either a single agent or as part of a ...
SuperGen Announces Study of Novel Regimen Using Nipent(R) for ... - PR Newswire (press release)
and more »
|
SuperGen says study shows new use for drugEast Bay Business Times
The road to forgiveness May 21, 2004
Ward-Kaiser. She was just finishing chemotherapy after battling three types of cancer -- skin, breast, and hairy-cell leukemia. But ... Monterey County Herald
Resources from the National Cancer Institute on hairy cell leukemia:
|
